Hearing loss associated with paromomycin treatment in a patient with visceral leishmaniasis

by Rocio Asensi-Diez, David Furones Araujo, Carmen Gallego Fernández
Published 2017-05-01

Nintedanib in combination with docetaxel for second-line treatment of advanced non-small-cell lung cancer; GENESIS-SEFH drug evaluation report

by María Espinosa Bosch, Rocío Asensi Diez, Sara García Agudo, Ana Clopes Estela
Published 2016-07-01

Docetaxel in hormone-sensitive advanced prostate cancer; GENESIS-SEFH evaluation reporta

by Emilio Jesús Alegre del Rey, Rocío Asensi Díez, Juan Carlos García de Paredes Esteban
Published 2017-07-01

Review of oritavancin for the treatment of acute bacterial skin and skin structure infections

by Ana Alejandra García Robles, Eduardo López Briz, María Dolores Fraga Fuentes, Rocío Asensi Diez, Jesús Francisco Sierra Sánchez
Published 2018-03-01

Economic evaluation of the GENESIS-SEFH report of olaratumab with doxorubicin in soft tissue sarcoma in advanced stages

by Juan Carlos del Río-Valencia, Rocío Asensi-Díez, M.ª Dolores Fraga-Fuentes, Ana Clopés-Estela, Lorenzo Villalobos-Torres
Published 2018-09-01

Vedolizumab in Crohn Disease genesis-sefh drug evaluation report

by Jenifer González Chávez, Rocio Asensi Diez, Rocío Tamayo Bermejo, Emilio Jesús Alegre del Rey, Noemí Martínez López de Castro
Published 2015-09-01

Spanish Society of Hospital Pharmacy position paper on biosimilar medicines

by Noemí Martínez-López de Castro, María Belén Matilla-Fernández, María Dolores Fraga-Fuentes, Irene Mangues-Bafalluy, Rocío Asensi-Díez, Gerardo Cajaraville-Ordoñana
Published 2018-07-01